Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.69 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Bicycle Therapeutics (BCYC) Construction in Progress (2022 - 2023)

Updated

Bicycle Therapeutics (BCYC) posted Construction in Progress of $400,000 for Q2 2023.

Analysis

Bicycle Therapeutics (BCYC) Construction in Progress (2022 - 2023) Analysis & Trends

At the end of FY2022, Bicycle Therapeutics' Construction in Progress came in at $2.3 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Bicycle Therapeutics 258.27 Mn -1.91 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 400,000.00
Dec 31, 2022 2.30 Mn
API Access

Bicycle Therapeutics Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=BCYC&period=max&api_key=YOUR_API_KEY